SABALESE Trademark

Trademark Overview


On Thursday, December 18, 2008, a trademark application was filed for SABALESE with the United States Patent and Trademark Office. The USPTO has given the SABALESE trademark a serial number of 77635702. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 9, 2010. This trademark is owned by Pfizer Inc.. The SABALESE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital and urological, viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, obesity, pain, sexual dysfunction; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; pharmaceutical preparations for the treatment of diabetes
sabalese

General Information


Serial Number77635702
Word MarkSABALESE
Filing DateThursday, December 18, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 9, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2009

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital and urological, viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, obesity, pain, sexual dysfunction; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; pharmaceutical preparations for the treatment of diabetes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 22, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, August 9, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 9, 2010ABANDONMENT - NO USE STATEMENT FILED
Friday, February 5, 2010EXTENSION 1 GRANTED
Monday, December 28, 2009EXTENSION 1 FILED
Wednesday, February 3, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 28, 2009TEAS EXTENSION RECEIVED
Tuesday, July 7, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2009NOTICE OF PUBLICATION
Tuesday, March 10, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 10, 2009ASSIGNED TO LIE
Monday, March 9, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 7, 2009ASSIGNED TO EXAMINER
Monday, December 22, 2008NEW APPLICATION ENTERED IN TRAM